Cohort of children with isolated nocturnal enuresis : a study of the safety of Minirinmelt in actual prescription FRESH-PEF185-en Martine MONDIET Cohort of children with isolated nocturnal enuresis : a study of the safety of Minirinmelt in actual prescription MENUI FRESH-PEF185-en 185 FRESH-PEF185 Philippe NIEZ FERRING SAS Epidemiology France Portal (PEF) FERRING SAS null Philippe;NIEZ desmopressin Minirin® tablet Minirinmelt® Endocrinology Paediatrics Andrology and urology Nocturnal enuresis Healthcare system determinants: Use of care Behavioral determinants Healthcare system determinants Show that the two oral forms (tablet and lyophilisate) of desmopressin have a similar safety profile and in particular in terms of frequency of the symptoms of alarms of an intoxication via water, in actual prescription situations, i.e. at general practitioners. null France Individuals Patients population Male Female Child (6 to 12 years) Criteria for inclusion: -patient having an isolated nocturnal enuresis, defined by the number of wet nights per week, -patient aged 6 to 18 years, -patient in which the family doctor has decided to prescribe a treatment via desmopressin, or Minirin® tablets or Minirinmelt® lyophilisate. patient who has already received prior treatment via desmopressin regardless of its form,-patient who has a treatment in progress via desmopressin,-patient participating in a therapeutic study. Clinical data Participant-reported health data Biological data Quality of life/health perception Others Other Through organizations (health services or institutions schools businesses etc.) [500-1000[ individuals Self-administered questionnaire Converting or copying information into a structured record Observational Study Observational Study 750 Unknown To be defined Access on specific project only